RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 53 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,743,031 | +16.0% | 886,075 | 0.0% | 2.78% | -2.4% |
| Q2 2023 | $5,812,652 | +9.7% | 886,075 | 0.0% | 2.85% | +11.6% |
| Q1 2023 | $5,298,729 | +156.7% | 886,075 | 0.0% | 2.55% | +87.1% |
| Q4 2022 | $2,064,555 | -30.4% | 886,075 | 0.0% | 1.36% | -30.8% |
| Q3 2022 | $2,968,000 | +26.4% | 886,075 | 0.0% | 1.97% | +17.7% |
| Q2 2022 | $2,348,000 | -9.9% | 886,075 | 0.0% | 1.68% | +19.1% |
| Q1 2022 | $2,605,000 | -65.6% | 886,075 | 0.0% | 1.41% | -47.4% |
| Q4 2021 | $7,576,000 | +14.8% | 886,075 | 0.0% | 2.67% | +103.1% |
| Q3 2021 | $6,601,000 | -20.2% | 886,075 | 0.0% | 1.32% | -0.6% |
| Q2 2021 | $8,267,000 | – | 886,075 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $6,384,000 | 9.38% |
| Abingworth LLP | 2,073,957 | $5,413,000 | 1.73% |
| Aisling Capital Management LP | 886,075 | $2,348,000 | 1.68% |
| NEA Management Company, LLC | 4,786,921 | $12,685,000 | 0.65% |
| Novo Holdings A/S | 3,430,377 | $9,090,000 | 0.45% |
| Ikarian Capital, LLC | 185,597 | $491,000 | 0.09% |
| Rock Springs Capital Management LP | 1,143,185 | $3,029,000 | 0.09% |
| Newtyn Management, LLC | 20,983 | $56,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $186,000 | 0.00% |
| Ergoteles LLC | 42,400 | $112,000 | 0.00% |